APA (7th ed.) Citation

Blumer, V., Rivera, M., Corbalán, R., Becker, R. C., Berkowitz, S. D., Breithardt, G., . . . Patel, M. R. (2021). Rivaroxaban versus warfarin in patients with atrial fibrillation enrolled in Latin America: Insights from ROCKET AF. American heart journal, 236, . https://doi.org/10.1016/j.ahj.2021.02.004

Chicago Style (17th ed.) Citation

Blumer, Vanessa, et al. "Rivaroxaban Versus Warfarin in Patients with Atrial Fibrillation Enrolled in Latin America: Insights from ROCKET AF." American Heart Journal 236 (2021). https://doi.org/10.1016/j.ahj.2021.02.004.

MLA (9th ed.) Citation

Blumer, Vanessa, et al. "Rivaroxaban Versus Warfarin in Patients with Atrial Fibrillation Enrolled in Latin America: Insights from ROCKET AF." American Heart Journal, vol. 236, 2021, https://doi.org/10.1016/j.ahj.2021.02.004.